Childhood Cancers

The Food and Drug Administration approved Koselugo to treat pediatric patients aged 2 years or older with neurofibromatosis type 1, a rare genetic disorder that causes tumors to grow on nerves.

A microsimulation model found that evolving approaches are associated with improved life expectancy among childhood cancer survivors – particularly for those who received chemotherapy alone.

New strategies are needed to help adolescent and young adult cancer survivors get follow-up care.

For a variety of reasons, some AYAs disappear from the health care system during the transition from treatment to survivorship and do not get the medical follow-up they require.

Going back to school after finishing cancer treatment can be exciting yet anxiety-inducing for a child — and a parent. Memorial Sloan Kettering neuropsychologist and child psychologist Stephen Sands has tips to help make the transition smoother.

For Childhood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

Through a children’s book that describes a fanciful dream, an author/illustrator remembers a youngster lost to cancer — and raises funds to boost research.

Although survival among AYAs with cancer has improved over recent decades, disparities within the severity of stage, race/ethnicity and socioeconomic status are still just as prevalent.

Children born to women who are considered severely obese have greater chances of developing cancer before the age of 5, according to new study findings.

Rachel Steele, B.S.N., RN, OCN, is an extraordinary healer. As one of the only pediatric nurses in an adult-focused cancer hospital and radiation oncology department, Rachel has intangible ways of connecting with families and children that engender instant comfort in such an overwhelming environment.

I am privileged and honored to nominate Miami Cancer Institute (MCI) pediatric oncology nurse Alicia De Pazos, RN, CPHON, for the 2019 CURE® Extraordinary Healer® Award. Alicia has been a pediatric oncology nurse for over 32 years. In that time, she has held many different positions — all in the pediatric oncology setting.

Cancer can bring about post-traumatic stress disorder that can linger for many years in both survivors of childhood cancer and their parents.

This essay, written by oncology nurse Karen Leary, Ruth & Raymond Perelman Center for Advanced Medicine, nominates fellow registered nurse and colleague Megan Lackaye for CURE®’s 2019 Extraordinary Healer® Award.

What a force they were, those two daughters of ours: that little nine-year-old kid Valerie, gone from bone cancer and the more grown-up 37-year-old Stacy, cut off by breast cancer. When we talk of them, however, it is often with a slight grin.

$600,000 grant awarded over three years at Boston Children’s Hospital.

The V Foundation for Cancer Research and ESPN Hall of Fame Sportscaster Dick Vitale are pleased to announce the 14th Annual Dick Vitale Gala raised more than $4.3 million for pediatric cancer research.

"Caitlin is an exceptionally talented and gifted nurse who has the rare and enviable combination of empathy, curiosity, intellectual fortitude and social acumen that has made her an extraordinary healer and leader," said James LaBelle, M.D., Ph.D., in the winning essay nominating Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON for the CURE® Extraordinary Healer® Award for Oncology Nursing.

The winner of the CURE® Extraordinary Healer® Award for Oncology Nursing discussed the bonds formed between patients with cancer and their health care team.

An interview with Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON, winner of the CURE® Extraordinary Healer® Award.

A hospital whose mission is to cure children’s catastrophic diseases is not only providing treatment, but also conducting research and making new medicines. Now, in addition to improving its patient-care and research capabilities, it plans to reach into low-income countries to help cure more children with cancer.

The Childhood Solid Tumor Network at St. Jude is helping scientists inside and outside the hospital’s walls to expand treatment options for youngsters with these cancers.

From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.

St. Jude Children’s Research Hospital is offering cloud-based access to the fully sequenced genomes of 10,000 pediatric patients with cancer, in the hopes that sharing the information will lead to the highest possible number of treatment breakthroughs.

Productivity loss among parent caregivers associated with poor health-related quality of life in pediatric advanced stage Hodgkin lymphoma.

Event to Fund Cutting-Edge Pediatric Cancer Research

President Donald J. Trump announced his plan to amp up the fight against childhood cancer, and to lower prescription drug costs.

Certain groups of pediatric and adolescent patients are less likely to receive fertility preservation consultation, recent research says.

This week, we spoke with the co-founder of a nonprofit organization dedicated to funding research to eliminate childhood cancer, as well as two families who have benefitted from the research being done in this area.

The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

AN ANTIOXIDANT APPROVED FOR use as an antidote to cyanide poisoning may also prevent hearing loss, a potential side effect of the chemotherapy drug cisplatin, in children who take the anticancer drug.